SlideShare a Scribd company logo
1 of 34
Download to read offline
Diffusion-weighted MR imaging for differentiating
borderline from malignant epithelial tumours of
the ovary: pathological correlation
DWI borderline / malignant epithelial ovarian tumors
Introduction
Borderline epithelial ovarian tumours (BEOTs), also
known as tumours of low malignant potential, account
for 4–14 % of all epithelial ovarian tumours (EOTs).
Although uncommon, peritoneal implants or metastatic
lymphadenopathy may occur in patients with BEOTs.
Clinically, BEOTs are distinct from ovarian malignant
epithelial tumours (MEOTs) in that they often affect
young women of childbearing age.
Patients with BEOTs are more likely to have early stage
disease, and generally have an excellent prognosis after
surgical excision but a high recurrence rate.
It is important to preoperatively discriminate BEOTs from
MEOTs because a conservative fertility-sparing
laparoscopic surgery can be performed in the former.
Magnetic resonance (MR) imaging is gaining recognition as
a complementary method to ultrasound in the diagnosis of
complex adnexal masses because of its excellent capacity
for tissue characterization.
The addition of DW imaging to conventional MR imaging
seems to improve accuracy in differentiating benign from
malignant ovarian lesions.
Concerning ovarian lesions; Thomassin-Naggara reported
that simultaneously low signal intensity within the solid
component on T2-weighted and on b 1000 DWI suggested
benignity of complex adnexal mass.
To authors’ knowledge, the utility of DW imaging in the
differentiation of BEOTs and MEOTs has not been
reported.
The purpose of this study was to investigate whether DW
imaging is a useful tool in distinguishing BEOTs from
MEOTs.
Materials and methods
Study population
This retrospective study was approved by authors’
institutional review boards and informed consent was
obtained from all patients.
Patients with suspected ovarian tumours on the basis of
elevated CA 125 level, ultrasound or CT were enrolled in
an ovarian tumour MR imaging study project from
October 2009 to September 2012.
Among 365 cases proven by surgery and pathology, a
total of 102 patients were found with non-benign EOT
including 60 BEOTs in 48 patients and 65 MEOTs in 54
patients.
Study population
Patients’ ages ranged from 17 to 71 years (mean, 39.5±15.3
years) in the borderline group and 40–75 years (mean, 55.3±9.4
years) in the malignant group.
The radical surgery, consisting of TAH+BSO, omentectomy,
multiple peritoneal biopsies, retroperitoneal lymph node
sampling, and cytological analyses of ascitic or peritoneal lavage
fluid, was performed in 70 patients (16 patients with BOETs and
54 patients with MEOTs).
The non-conservative surgery of BSO with or without
hysterectomy was performed in 19 patients with BEOTs.
The conservative surgery of unilateral salpingo-oophorectomy
was performed in 13 patients with BEOTs.
DWI borderline / malignant epithelial ovarian tumors
MR imaging technique
MR imaging was performed using a 1.5-T unit (Avanto or
Symphony, Siemens, Erlangen, Germany) with a phased
array coil.
Spasmolytic drugs were not administrated.
Patients in the supine position breathed freely during
acquisition.
The imaging range was from the inferior pubic symphysis
to the renal hilum and was extended beyond the dome of
tumour in the cases with huge masses.
MR imaging technique
Routine pelvic MR images were acquired as follows:
Axial T1-weighted imaging (T1WI).
Axial T1WI with fat suppression
Axial and sagittal T2-weighted imaging (T2WI) with or without fat
suppression.
Axial DW imaging was then obtained using echo planer imaging
sequence with diffusion gradient b factors, 0 and 1,000 s/mm2;
and acquisition time, 2 min 46 s.
Axial dynamic gadolinium-enhanced fat-suppressed T1WI was
performed immediately after intravenous injection of 0.1
mmol/kg of contrast material at a flow of 2.5 ml/s;
MR image analysis
MR images were read by two radiologists in consensus with
10 and 29 years of experience in gynaecological imaging.
Both of the radiologists were blinded to the clinical data of
patients.
The morphological features (tumour size, presence of solid
component) were determined on T2WI and contrast-
enhanced T1WI.
The term “solid component” included the solid portions,
papillary projections and thickened septa (larger than 5
mm).
MR image analysis
The signal intensity (SI) of tumour on DW imaging was
classified as high (similar to the SI of nerve root), moderate
(similar to small intestine) or low (lower than small
intestine).
On the ADC maps, a circular region of interest (ROI) of at
least 1 cm2 was placed at targeted areas with the possibly
lowest ADC values in the cystic and/or solid components of
tumour, by referring to conventional MR images, including
contrast-enhanced images and carefully avoiding areas
such as haemorrhage, necrosis, major vascular structures,
and artefacts such as chemical shift and magnetic
susceptibility artefacts.
MR image analysis
To eliminate the potential influence of intraindividual
correlation in patients with bilateral tumours (n=23), only
the results for the most complex tumour were considered;
thus, 102 tumours (48 BEOTs, 54MEOTs) were evaluated.
Also the analysis of ADC values of solid components
smaller than 10 mm (10 BEOTs and 3 MEOTs) were
excluded because of low contrast-to-noise ratio and
motion artefacts.
At least three measurements were obtained and averaged.
Histopathological evaluation
The histopathological examination was performed by a
pathologist with 12 years of experience in
gynaecological pathology.
After that statistical analysis was performed.
Results
Pathological findings
Gross pathology confirmed MR morphological findings.
DW imaging findings
The mean ADC value and DW imaging SI of the cystic
component did not differ significantly between the two
groups.
Axial T2- weighted with fat suppression (a) and T1-weighted contrast enhanced images (b)
demonstrate a cystic mass with multiple septa and a papillary projection extending from
the cyst wall. The projection (arrow) shows high signal intensity on DW imaging (c) and has
an ADC value of 0.607×10−3 mm2/s (d)
A 42-year-old woman with ovarian mixed adenocarcinoma.
Axial T2-weighted with fat suppression (a) and T1-weighted contrast enhanced images (b)
demonstrate a solid mass (arrow). The mass shows high signal intensity on DW imaging (c)
and has an ADC value of 0.891×10−3 mm2/s.
A 40-year-old woman with ovarian serous adenocarcinoma.
Axial T2-weighted with fat suppression (a) and T1-weighted contrast-enhanced images (b)
show a unilocular cystic lesion with a large papillary projection demonstrating obvious
contrast enhancement (arrow). The papillary projection shows moderate signal intensity on
DW imaging (c) and has an ADC value of 1.486×10−3 mm2/s (d).
A 20-year-old woman with ovarian serous borderline tumour.
Axial T2-weighted with fat suppression (a) and T1-weighted contrast enhanced images (b)
demonstrate a right-sided solid mass (arrows) and a left-sided cystic mass with intracystic
papillary projections. The solid component shows low to moderate signal intensity on DW
imaging (c) and an ADC value of 1.975×10−3 mm2/s and 1.869×10−3 mm2/s in the right and
left masses, respectively.
A 27-year-old woman with bilateral ovarian serous borderline tumours.
Discussion
MR imaging has shown a high diagnostic specificity for
some types of ovarian masses, such as dermoid cysts,
endometrial cysts and fibromas. However, there is no
specific role for conventional MR imaging in
characterizing borderline and malignant EOTs.
The presence of a contrast-enhanced solid component
may be useful for distinguishing malignant from benign
epithelial tumours but not for borderline from malignant
tumours.
In this study, most (54/60) BEOTs demonstrated at least
one of the imaging features which were recognized to be
associated with malignancy, such as irregularly thickened
wall, enhancing vegetation and predominantly solid mass.
Some studies show that DW imaging can differentiate
malignant from benign ovarian tumours with higher DWI SI
and lower ADC values in malignant tumours. However, no
significant ADC value difference was found between the
two groups.
The inconsistent results are probably due to the diversity
of samples and histopathological complexity of the ovarian
tumours.
Also some benign solid tumours such as teratomas or
fibrothecomas have lower ADC values that compromise the
higher ADC values in benign and borderline epithelial
tumours.
So, in this study, these non-epithelial tumours were ruled
out because of their characteristic findings on conventional
MR imaging.
In this study, most BEOTs demonstrated low or moderate
SI in the solid component on DW imaging, whereas almost
all MEOTs demonstrated high SI in the solid component.
The mean ADC value of the solid component in BEOTs was
much higher than in MEOTs.
Furthermore, the study showed an optimal ADC value
threshold of 1.039×10−3 mm2/s for differentiating
borderline from malignant tumours with a sensitivity of
97.0%, a specificity of 92.2% and an accuracy of 96.4 %.
When the solid component was too small to measure
the ADC value, a high DW imaging SI often suggested a
MEOT.
Therefore, both the assessments of DW imaging SI and
ADC value were useful in differentiating BEOTs from
MEOTs.
Although the radical surgery is the usual treatment for
BEOTs, the need for this procedure is controversial, as no
significant differences in the recurrence and mortality
between patients with radical and conservative surgeries
have been observed.
The conservative surgery has been recommended in
young patients with an early stage BEOT, even with a
stage II, III or IV BEOT, if they wish to maintain their
fertility.
The accurate characterization of BEOTs in the present
study will encourage the implementation of conservative
fertility-sparing surgery, especially the minimally invasive
laparoscopic surgery.
Limitations of the study
First, DW imaging was acquired through free-breathing
imaging which may affect the ADC value of lesions,
especially huge cystic lesions.
Second, the precise matching of histological specimens
taken for cell density measurement to the ADC value
measurement of the tumour may be difficult in the
mucinous BEOTs.
Third, the ADC value of solid component was not assessed
in 10 of 48 BEOTs and 3 of 54 MEOTs, as the solid
component was smaller than 1 cm.
Fourth, the ADC value threshold is machine-specific and
probably not universal.
Conclusion
The utility of DW imaging can discriminate BEOTs
from MEOTs, thereby improving the accuracy of
pretreatment and surgical management of EOTs.
Thank You

More Related Content

What's hot

Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahAyub Medical College
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancermrhaakgyn
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancerpaviarun
 
Ovarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after DiagnosisOvarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after DiagnosisSibley Memorial Hospital
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancerfitango
 
Gynaecological cancers staging and treatment
Gynaecological cancers   staging and treatmentGynaecological cancers   staging and treatment
Gynaecological cancers staging and treatmentsailakshmidaayana
 
Endometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHEndometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHNeha Jain
 
Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...
Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...
Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...European School of Oncology
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS JalandharDr H.K. Cheema
 
Ca ovary dr. varun
Ca ovary  dr. varunCa ovary  dr. varun
Ca ovary dr. varunVarun Goel
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA OvaryAnil Gupta
 
The Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian CancerThe Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian CancerSibley Memorial Hospital
 

What's hot (20)

Ovarian Carcinoma
Ovarian CarcinomaOvarian Carcinoma
Ovarian Carcinoma
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullah
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Ovarian tumor byDr rahim
Ovarian tumor byDr rahimOvarian tumor byDr rahim
Ovarian tumor byDr rahim
 
Ovarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after DiagnosisOvarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after Diagnosis
 
Gynecology 5th year, 7th lecture/part two (Dr. Sindus)
Gynecology 5th year, 7th lecture/part two (Dr. Sindus)Gynecology 5th year, 7th lecture/part two (Dr. Sindus)
Gynecology 5th year, 7th lecture/part two (Dr. Sindus)
 
Endometrial Cancer
Endometrial CancerEndometrial Cancer
Endometrial Cancer
 
Gynaecological cancers staging and treatment
Gynaecological cancers   staging and treatmentGynaecological cancers   staging and treatment
Gynaecological cancers staging and treatment
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Endometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHEndometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARH
 
Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...
Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...
Medical Students 2011 - J.B. Vermorken - GYNAECOLOGICAL CANCER SESSION - Epit...
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
 
Ca ovary dr. varun
Ca ovary  dr. varunCa ovary  dr. varun
Ca ovary dr. varun
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
 
Endo ca
Endo caEndo ca
Endo ca
 
ovarian tumor
ovarian tumorovarian tumor
ovarian tumor
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometrium
 
The Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian CancerThe Role of Surgery in the Management of Ovarian Cancer
The Role of Surgery in the Management of Ovarian Cancer
 

Viewers also liked

Presentation1.pptx, radilogical imaging of ovarian lesions.
Presentation1.pptx, radilogical imaging of ovarian lesions.Presentation1.pptx, radilogical imaging of ovarian lesions.
Presentation1.pptx, radilogical imaging of ovarian lesions.Abdellah Nazeer
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumorsDr Anusha Rao P
 
Ovarian cancer ppt
Ovarian cancer pptOvarian cancer ppt
Ovarian cancer pptVidya Dhonde
 
Download presentation
Download presentationDownload presentation
Download presentationwebhostingguy
 

Viewers also liked (8)

Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
15
1515
15
 
Presentation1.pptx, radilogical imaging of ovarian lesions.
Presentation1.pptx, radilogical imaging of ovarian lesions.Presentation1.pptx, radilogical imaging of ovarian lesions.
Presentation1.pptx, radilogical imaging of ovarian lesions.
 
Ca Ovary
Ca OvaryCa Ovary
Ca Ovary
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumors
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Ovarian cancer ppt
Ovarian cancer pptOvarian cancer ppt
Ovarian cancer ppt
 
Download presentation
Download presentationDownload presentation
Download presentation
 

Similar to DWI borderline / malignant epithelial ovarian tumors

Presentation1, radiological imaging of endometrial carcinoma.
Presentation1, radiological imaging of endometrial carcinoma.Presentation1, radiological imaging of endometrial carcinoma.
Presentation1, radiological imaging of endometrial carcinoma.Abdellah Nazeer
 
Presentation1, radiological imaging of anal carcinoma.
Presentation1, radiological imaging of anal carcinoma.Presentation1, radiological imaging of anal carcinoma.
Presentation1, radiological imaging of anal carcinoma.Abdellah Nazeer
 
Suspicious ovarian masses
Suspicious ovarian massesSuspicious ovarian masses
Suspicious ovarian massesAhmed Elagwany
 
Endometrial vascularity
Endometrial vascularityEndometrial vascularity
Endometrial vascularityhartatieknila
 
Jean Yves Seror : Breast cancer : Small lesion imaging features
Jean Yves Seror  : Breast cancer : Small lesion imaging featuresJean Yves Seror  : Breast cancer : Small lesion imaging features
Jean Yves Seror : Breast cancer : Small lesion imaging featuresbreastcancerupdatecongress
 
Treatment of Muscle Invasive Bladder Carcinoma
Treatment of Muscle Invasive Bladder Carcinoma Treatment of Muscle Invasive Bladder Carcinoma
Treatment of Muscle Invasive Bladder Carcinoma Dr.Bhavin Vadodariya
 
Ductal Carcinoma In Situ (DCIS)
Ductal Carcinoma In Situ  (DCIS)Ductal Carcinoma In Situ  (DCIS)
Ductal Carcinoma In Situ (DCIS)Mohammed Fathy
 
rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...
rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...
rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...jim kuok
 
Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...
Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...
Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...Mauricio Lema
 
Role of Tomosynthesis in Assessing the Size of the Breast Lesion
Role of Tomosynthesis in Assessing the Size of the Breast LesionRole of Tomosynthesis in Assessing the Size of the Breast Lesion
Role of Tomosynthesis in Assessing the Size of the Breast LesionApollo Hospitals
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...JohnJulie1
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...daranisaha
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...EditorSara
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...semualkaira
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...NainaAnon
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...semualkaira
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...EditorSara
 
CARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTCARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTNabeel Yahiya
 

Similar to DWI borderline / malignant epithelial ovarian tumors (20)

Presentation1, radiological imaging of endometrial carcinoma.
Presentation1, radiological imaging of endometrial carcinoma.Presentation1, radiological imaging of endometrial carcinoma.
Presentation1, radiological imaging of endometrial carcinoma.
 
Presentation1, radiological imaging of anal carcinoma.
Presentation1, radiological imaging of anal carcinoma.Presentation1, radiological imaging of anal carcinoma.
Presentation1, radiological imaging of anal carcinoma.
 
Suspicious ovarian masses
Suspicious ovarian massesSuspicious ovarian masses
Suspicious ovarian masses
 
MCC 2011 - Slide 2
MCC 2011 - Slide 2MCC 2011 - Slide 2
MCC 2011 - Slide 2
 
Endometrial vascularity
Endometrial vascularityEndometrial vascularity
Endometrial vascularity
 
Jean Yves Seror : Breast cancer : Small lesion imaging features
Jean Yves Seror  : Breast cancer : Small lesion imaging featuresJean Yves Seror  : Breast cancer : Small lesion imaging features
Jean Yves Seror : Breast cancer : Small lesion imaging features
 
Treatment of Muscle Invasive Bladder Carcinoma
Treatment of Muscle Invasive Bladder Carcinoma Treatment of Muscle Invasive Bladder Carcinoma
Treatment of Muscle Invasive Bladder Carcinoma
 
Ductal Carcinoma In Situ (DCIS)
Ductal Carcinoma In Situ  (DCIS)Ductal Carcinoma In Situ  (DCIS)
Ductal Carcinoma In Situ (DCIS)
 
rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...
rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...
rectal cancer staging;Imaging for rectal cancer staging -Endoscopic ultrasoun...
 
Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...
Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...
Controversias en cancer de pulmón oligometastásico (tratamiento sistémico vs ...
 
Role of Tomosynthesis in Assessing the Size of the Breast Lesion
Role of Tomosynthesis in Assessing the Size of the Breast LesionRole of Tomosynthesis in Assessing the Size of the Breast Lesion
Role of Tomosynthesis in Assessing the Size of the Breast Lesion
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
Breast MR Imaging Helps Differentiate Malignant and Benign Mammographic Micro...
 
CARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTCARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENT
 
Rectal cancer
Rectal cancerRectal cancer
Rectal cancer
 

More from Naglaa Mahmoud

Radiology night 10/2015
Radiology night 10/2015Radiology night 10/2015
Radiology night 10/2015Naglaa Mahmoud
 
Gestational trophoblastic disease
Gestational trophoblastic diseaseGestational trophoblastic disease
Gestational trophoblastic diseaseNaglaa Mahmoud
 
Treatment related complications from Chemothearpy
Treatment related complications from ChemothearpyTreatment related complications from Chemothearpy
Treatment related complications from ChemothearpyNaglaa Mahmoud
 
Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients Naglaa Mahmoud
 
Secondary Peritoneal Disease
Secondary Peritoneal DiseaseSecondary Peritoneal Disease
Secondary Peritoneal DiseaseNaglaa Mahmoud
 
Digital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, MicrocalcificationsDigital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, MicrocalcificationsNaglaa Mahmoud
 
Breast Cancer not Detected on MRI
Breast Cancer not Detected on MRIBreast Cancer not Detected on MRI
Breast Cancer not Detected on MRINaglaa Mahmoud
 
Incidental Adnexal Masses at CT
Incidental Adnexal Masses at CTIncidental Adnexal Masses at CT
Incidental Adnexal Masses at CTNaglaa Mahmoud
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced NephropathyNaglaa Mahmoud
 

More from Naglaa Mahmoud (12)

Breast bpe
Breast bpe Breast bpe
Breast bpe
 
Radiology night 10/2015
Radiology night 10/2015Radiology night 10/2015
Radiology night 10/2015
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Gestational trophoblastic disease
Gestational trophoblastic diseaseGestational trophoblastic disease
Gestational trophoblastic disease
 
Treatment related complications from Chemothearpy
Treatment related complications from ChemothearpyTreatment related complications from Chemothearpy
Treatment related complications from Chemothearpy
 
Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients
 
Secondary Peritoneal Disease
Secondary Peritoneal DiseaseSecondary Peritoneal Disease
Secondary Peritoneal Disease
 
Digital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, MicrocalcificationsDigital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, Microcalcifications
 
Breast Cancer not Detected on MRI
Breast Cancer not Detected on MRIBreast Cancer not Detected on MRI
Breast Cancer not Detected on MRI
 
Incidental Adnexal Masses at CT
Incidental Adnexal Masses at CTIncidental Adnexal Masses at CT
Incidental Adnexal Masses at CT
 
H&N post ttt
H&N post tttH&N post ttt
H&N post ttt
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 

DWI borderline / malignant epithelial ovarian tumors

  • 1. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation
  • 4. Borderline epithelial ovarian tumours (BEOTs), also known as tumours of low malignant potential, account for 4–14 % of all epithelial ovarian tumours (EOTs). Although uncommon, peritoneal implants or metastatic lymphadenopathy may occur in patients with BEOTs. Clinically, BEOTs are distinct from ovarian malignant epithelial tumours (MEOTs) in that they often affect young women of childbearing age. Patients with BEOTs are more likely to have early stage disease, and generally have an excellent prognosis after surgical excision but a high recurrence rate.
  • 5. It is important to preoperatively discriminate BEOTs from MEOTs because a conservative fertility-sparing laparoscopic surgery can be performed in the former. Magnetic resonance (MR) imaging is gaining recognition as a complementary method to ultrasound in the diagnosis of complex adnexal masses because of its excellent capacity for tissue characterization. The addition of DW imaging to conventional MR imaging seems to improve accuracy in differentiating benign from malignant ovarian lesions.
  • 6. Concerning ovarian lesions; Thomassin-Naggara reported that simultaneously low signal intensity within the solid component on T2-weighted and on b 1000 DWI suggested benignity of complex adnexal mass. To authors’ knowledge, the utility of DW imaging in the differentiation of BEOTs and MEOTs has not been reported. The purpose of this study was to investigate whether DW imaging is a useful tool in distinguishing BEOTs from MEOTs.
  • 8. Study population This retrospective study was approved by authors’ institutional review boards and informed consent was obtained from all patients. Patients with suspected ovarian tumours on the basis of elevated CA 125 level, ultrasound or CT were enrolled in an ovarian tumour MR imaging study project from October 2009 to September 2012. Among 365 cases proven by surgery and pathology, a total of 102 patients were found with non-benign EOT including 60 BEOTs in 48 patients and 65 MEOTs in 54 patients.
  • 9. Study population Patients’ ages ranged from 17 to 71 years (mean, 39.5±15.3 years) in the borderline group and 40–75 years (mean, 55.3±9.4 years) in the malignant group. The radical surgery, consisting of TAH+BSO, omentectomy, multiple peritoneal biopsies, retroperitoneal lymph node sampling, and cytological analyses of ascitic or peritoneal lavage fluid, was performed in 70 patients (16 patients with BOETs and 54 patients with MEOTs). The non-conservative surgery of BSO with or without hysterectomy was performed in 19 patients with BEOTs. The conservative surgery of unilateral salpingo-oophorectomy was performed in 13 patients with BEOTs.
  • 11. MR imaging technique MR imaging was performed using a 1.5-T unit (Avanto or Symphony, Siemens, Erlangen, Germany) with a phased array coil. Spasmolytic drugs were not administrated. Patients in the supine position breathed freely during acquisition. The imaging range was from the inferior pubic symphysis to the renal hilum and was extended beyond the dome of tumour in the cases with huge masses.
  • 12. MR imaging technique Routine pelvic MR images were acquired as follows: Axial T1-weighted imaging (T1WI). Axial T1WI with fat suppression Axial and sagittal T2-weighted imaging (T2WI) with or without fat suppression. Axial DW imaging was then obtained using echo planer imaging sequence with diffusion gradient b factors, 0 and 1,000 s/mm2; and acquisition time, 2 min 46 s. Axial dynamic gadolinium-enhanced fat-suppressed T1WI was performed immediately after intravenous injection of 0.1 mmol/kg of contrast material at a flow of 2.5 ml/s;
  • 13. MR image analysis MR images were read by two radiologists in consensus with 10 and 29 years of experience in gynaecological imaging. Both of the radiologists were blinded to the clinical data of patients. The morphological features (tumour size, presence of solid component) were determined on T2WI and contrast- enhanced T1WI. The term “solid component” included the solid portions, papillary projections and thickened septa (larger than 5 mm).
  • 14. MR image analysis The signal intensity (SI) of tumour on DW imaging was classified as high (similar to the SI of nerve root), moderate (similar to small intestine) or low (lower than small intestine). On the ADC maps, a circular region of interest (ROI) of at least 1 cm2 was placed at targeted areas with the possibly lowest ADC values in the cystic and/or solid components of tumour, by referring to conventional MR images, including contrast-enhanced images and carefully avoiding areas such as haemorrhage, necrosis, major vascular structures, and artefacts such as chemical shift and magnetic susceptibility artefacts.
  • 15. MR image analysis To eliminate the potential influence of intraindividual correlation in patients with bilateral tumours (n=23), only the results for the most complex tumour were considered; thus, 102 tumours (48 BEOTs, 54MEOTs) were evaluated. Also the analysis of ADC values of solid components smaller than 10 mm (10 BEOTs and 3 MEOTs) were excluded because of low contrast-to-noise ratio and motion artefacts. At least three measurements were obtained and averaged.
  • 16. Histopathological evaluation The histopathological examination was performed by a pathologist with 12 years of experience in gynaecological pathology. After that statistical analysis was performed.
  • 18. Pathological findings Gross pathology confirmed MR morphological findings.
  • 19. DW imaging findings The mean ADC value and DW imaging SI of the cystic component did not differ significantly between the two groups.
  • 20. Axial T2- weighted with fat suppression (a) and T1-weighted contrast enhanced images (b) demonstrate a cystic mass with multiple septa and a papillary projection extending from the cyst wall. The projection (arrow) shows high signal intensity on DW imaging (c) and has an ADC value of 0.607×10−3 mm2/s (d) A 42-year-old woman with ovarian mixed adenocarcinoma.
  • 21. Axial T2-weighted with fat suppression (a) and T1-weighted contrast enhanced images (b) demonstrate a solid mass (arrow). The mass shows high signal intensity on DW imaging (c) and has an ADC value of 0.891×10−3 mm2/s. A 40-year-old woman with ovarian serous adenocarcinoma.
  • 22. Axial T2-weighted with fat suppression (a) and T1-weighted contrast-enhanced images (b) show a unilocular cystic lesion with a large papillary projection demonstrating obvious contrast enhancement (arrow). The papillary projection shows moderate signal intensity on DW imaging (c) and has an ADC value of 1.486×10−3 mm2/s (d). A 20-year-old woman with ovarian serous borderline tumour.
  • 23. Axial T2-weighted with fat suppression (a) and T1-weighted contrast enhanced images (b) demonstrate a right-sided solid mass (arrows) and a left-sided cystic mass with intracystic papillary projections. The solid component shows low to moderate signal intensity on DW imaging (c) and an ADC value of 1.975×10−3 mm2/s and 1.869×10−3 mm2/s in the right and left masses, respectively. A 27-year-old woman with bilateral ovarian serous borderline tumours.
  • 25. MR imaging has shown a high diagnostic specificity for some types of ovarian masses, such as dermoid cysts, endometrial cysts and fibromas. However, there is no specific role for conventional MR imaging in characterizing borderline and malignant EOTs. The presence of a contrast-enhanced solid component may be useful for distinguishing malignant from benign epithelial tumours but not for borderline from malignant tumours.
  • 26. In this study, most (54/60) BEOTs demonstrated at least one of the imaging features which were recognized to be associated with malignancy, such as irregularly thickened wall, enhancing vegetation and predominantly solid mass. Some studies show that DW imaging can differentiate malignant from benign ovarian tumours with higher DWI SI and lower ADC values in malignant tumours. However, no significant ADC value difference was found between the two groups. The inconsistent results are probably due to the diversity of samples and histopathological complexity of the ovarian tumours.
  • 27. Also some benign solid tumours such as teratomas or fibrothecomas have lower ADC values that compromise the higher ADC values in benign and borderline epithelial tumours. So, in this study, these non-epithelial tumours were ruled out because of their characteristic findings on conventional MR imaging.
  • 28. In this study, most BEOTs demonstrated low or moderate SI in the solid component on DW imaging, whereas almost all MEOTs demonstrated high SI in the solid component. The mean ADC value of the solid component in BEOTs was much higher than in MEOTs. Furthermore, the study showed an optimal ADC value threshold of 1.039×10−3 mm2/s for differentiating borderline from malignant tumours with a sensitivity of 97.0%, a specificity of 92.2% and an accuracy of 96.4 %.
  • 29. When the solid component was too small to measure the ADC value, a high DW imaging SI often suggested a MEOT. Therefore, both the assessments of DW imaging SI and ADC value were useful in differentiating BEOTs from MEOTs.
  • 30. Although the radical surgery is the usual treatment for BEOTs, the need for this procedure is controversial, as no significant differences in the recurrence and mortality between patients with radical and conservative surgeries have been observed. The conservative surgery has been recommended in young patients with an early stage BEOT, even with a stage II, III or IV BEOT, if they wish to maintain their fertility. The accurate characterization of BEOTs in the present study will encourage the implementation of conservative fertility-sparing surgery, especially the minimally invasive laparoscopic surgery.
  • 32. First, DW imaging was acquired through free-breathing imaging which may affect the ADC value of lesions, especially huge cystic lesions. Second, the precise matching of histological specimens taken for cell density measurement to the ADC value measurement of the tumour may be difficult in the mucinous BEOTs. Third, the ADC value of solid component was not assessed in 10 of 48 BEOTs and 3 of 54 MEOTs, as the solid component was smaller than 1 cm. Fourth, the ADC value threshold is machine-specific and probably not universal.
  • 33. Conclusion The utility of DW imaging can discriminate BEOTs from MEOTs, thereby improving the accuracy of pretreatment and surgical management of EOTs.